Vis enkel innførsel

dc.contributor.authorSlattery, Jim
dc.contributor.authorQuinten, Chantal
dc.contributor.authorCandore, Gianmario
dc.contributor.authorPinheiro, Luis
dc.contributor.authorFlynn, Robert
dc.contributor.authorKurz, Xavier
dc.contributor.authorNordeng, Hedvig Marie Egeland
dc.date.accessioned2023-02-27T10:25:02Z
dc.date.available2023-02-27T10:25:02Z
dc.date.created2022-08-25T10:57:14Z
dc.date.issued2022
dc.identifier.citationBritish Journal of Clinical Pharmacology. 2022, 88 4526-4539.
dc.identifier.issn0306-5251
dc.identifier.urihttps://hdl.handle.net/11250/3054148
dc.language.isoeng
dc.titleOndansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
dc.title.alternativeOndansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber4526-4539
dc.source.volume88
dc.source.journalBritish Journal of Clinical Pharmacology
dc.identifier.doi10.1111/bcp.15370
dc.identifier.cristin2045911
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel